Although the antitumor effect of BRAF inhibitors in melanoma is significant 41, BRAFV600E mutant thyroid and colorectal cancer cell lines are insensitive to BRAF inhibitors 8, 21, 22. The gene discussed is BRAF; the disease is thyroiditis.